Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Sacks, F. M., L. J. Appel, T. J. Moore, E. Obarzanek, W. M. Vollmer, L. P. Svetkey, G. A. Bray, et al. “A dietary approach to prevent hypertension: A review of the dietary approaches to stop hypertension (DASH) study.” Clinical Cardiology 22, no. 7 SUPPL. (July 14, 1999).

Scholars@Duke

Sacks, F. M., L. J. Appel, T. J. Moore, E. Obarzanek, W. M. Vollmer, L. P. Svetkey, G. A. Bray, et al. “A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study..” Clin Cardiol 22, no. 7 Suppl (July 1999): III6-II10. https://doi.org/10.1002/clc.4960221503.

PMID
10410299
Full Text

Svetkey, L. P., D. Simons-Morton, W. M. Vollmer, L. J. Appel, P. R. Conlin, D. H. Ryan, J. Ard, and B. M. Kennedy. “Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial..” Arch Intern Med 159, no. 3 (February 8, 1999): 285–93. https://doi.org/10.1001/archinte.159.3.285.

PMID
9989541
Full Text

Vollmer, W. M., L. P. Svetkey, L. J. Appel, E. Obarzanek, P. Reams, B. Kennedy, K. Aicher, et al. “Recruitment and retention of minority participants in the DASH controlled feeding trial.” Ethnicity and Disease 8, no. 2 (December 1, 1998): 198–208.

Scholars@Duke

Moore, T. J., L. J. Appel, G. A. Bray, L. P. Svetkey, W. M. Vollmer, and D. A. McCarron. “More salt, please [5] (multiple letters).” Science 282, no. 5391 (November 6, 1998): 1049–51.

Scholars@Duke

Moore, T. J., L. J. Appel, G. A. Bray, L. P. Svetkey, and W. M. Vollmer. “More salt, please.” Science 282, no. 5391 (November 6, 1998): 1049–50.

Scholars@Duke

Chow, D. C., E. R. Miller, L. P. Svetkey, T. J. Moore, D. W. Harsha, and L. J. Appel. “The effect of dietary patterns on blood pressure and control of hypertension.” Circulation 98, no. 17 (October 27, 1998): 447–447.

Scholars@Duke

Weiss, M. F., R. A. Rodby, A. C. Justice, and D. E. Hricik. “Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group..” Kidney Int 54, no. 1 (July 1998): 193–202. https://doi.org/10.1038/sj.ki.4495352.

PMID
9648079
Full Text

Lacourcière, Y., J. L. Pool, L. Svetkey, A. H. Gradman, P. Larochelle, J. de Champlain, and W. B. Smith. “A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group..” Am J Hypertens 11, no. 4 Pt 1 (April 1998): 454–61. https://doi.org/10.1016/s0895-7061(97)00487-1.

PMID
9607384
Full Text

Pages